Presentations

Pancreatic Cancer


Presentations


Speakers

  • Eileen M. O'Reilly, MD

    Eileen M. O'Reilly, MD

    Eileen M. O'Reilly, MD

    Attending Physician, Member

    Eileen M. O’Reilly, MD, is associate director for clinical research, David M. Rubenstein Center for Pancreatic Cancer; Winthrop Rockefeller Endowed Chair in Medical Oncology; and attending physician and member at Memorial Sloan Kettering Cancer Center in New York, and professor of medicine at Weill Cornell Medical College. Dr O’Reilly’s research and clinical activities focus on pancreatic and hepatobiliary malignancies. Her research initiatives include integrating molecular and genetic-based therapies into pancreatic cancer treatment, developing adjuvant and neoadjuvant therapies, and identifying biomarkers that may be used to select therapy. She is the principal investigator of multiple pancreatic cancer trials and has authored/co-authored more than 250 articles, editorials, and book chapters.
  • Andrew H. Ko, MD, FASCO

    Andrew H. Ko, MD, FASCO

    Andrew H. Ko, MD, FASCO

    Professor and Interim Chief (Oncology)

    Andrew H. Ko, MD, FASCO, is a professor of clinical medicine and interim chief of oncology in the Division of Hematology/Oncology, and a member of the Helen Diller Family Comprehensive Cancer Center, at the University of California, San Francisco, where he also chairs both the Cancer Center Scientific Protocol and Gastrointestinal Cancer Site Committees. Dr Ko’s primary clinical and research interests center on gastrointestinal malignancies, with an emphasis on pancreatic and gastroesophageal cancers. He has received research funding from the National Cancer Institute (NCI) and National Comprehensive Cancer Network (NCCN), has led numerous clinical trials, and is is currently participating in and/or co-leading several national initiatives for patients with pancreatic cancer.